Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioXcel Therapeutics, Inc. - Common Stock
(NQ:
BTAI
)
0.1320
-0.0280 (-17.50%)
Streaming Delayed Price
Updated: 10:03 AM EDT, Sep 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioXcel Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
These stocks are moving in today's pre-market session
↗
Today 8:30 EDT
Via
Chartmill
On Monday, there are stocks with unusual volume. Let's take a look.
↗
August 31, 2026
Via
Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
↗
August 31, 2026
Via
Chartmill
Friday's session: top gainers and losers
↗
August 28, 2026
Via
Chartmill
BioXcel Stock Shoots Up 3% Pre-Market After Company Announces Positive Efficacy Data For Agitation Drug In Study
↗
September 10, 2025
Via
Stocktwits
BioXcel’s Sublingual Film Well-Tolerated In Bipolar, Schizophrenia Trial In At-Home Settings, Retail Says Buy Now Or Regret Later
↗
August 27, 2025
Via
Stocktwits
BioXcel Sparks Retail Frenzy As Stock Soars Ahead Of Phase 3 Results For Bipolar, Schizophrenia Drug
↗
August 27, 2025
Via
Stocktwits
Which stocks are experiencing notable movement on Friday?
↗
August 28, 2026
Via
Chartmill
Gapping stocks in Friday's session
↗
August 28, 2026
Via
Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
↗
August 28, 2026
Via
Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session.
↗
August 17, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
August 17, 2026
Via
Chartmill
Let's take a look at the stocks that are in motion in today's session.
↗
July 14, 2026
Via
Chartmill
Levi & Korsinsky, LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of BioXcel Therapeutics, Inc.
March 23, 2026
From
Levi & Korsinsky, LLP
Via
GlobeNewswire
The trading volume of these stocks is deviating from the norm in today's session.
↗
March 06, 2026
Via
Chartmill
Why Did BTAI Stock Surge 20% In Pre-Market Today?
↗
March 05, 2026
BioXcel announced positive Phase 2 results for evaluating treatment for opioid withdrawal symptoms.
Via
Stocktwits
Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
January 15, 2026
From
Halper Sadeh LLC
Via
Business Wire
Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
October 24, 2025
From
Halper Sadeh LLC
Via
Business Wire
BioXcel Drug Calms Agitation At Home For Schizophrenia, Bipolar Patients
↗
September 10, 2025
BioXcel's Phase 3 trial shows BXCL501 effectively reduces agitation in bipolar and schizophrenia patients, supporting its at-home treatment use.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
September 08, 2025
Via
Benzinga
EXCLUSIVE: August's 20 Most-Searched Tickers On Benzinga Pro – Where Do Opendoor, Palantir, BitMine Immersion, Apple Stock Rank?
↗
September 02, 2025
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.
Via
Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
August 27, 2025
Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
August 27, 2025
Via
Benzinga
Which stocks are experiencing notable movement on Wednesday?
↗
August 27, 2025
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.
Via
Chartmill
BioXcel Seeks FDA Label Expansion For Schizophrenia Treatment
↗
August 27, 2025
BioXcel's Phase 3 trial shows BXCL501 safely reduces agitation in schizophrenia patients, supporting plans for an FDA label expansion.
Via
Benzinga
The market is filled with gapping stocks in Wednesday's session.
↗
August 27, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.
Via
Chartmill
Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket
↗
August 27, 2025
Via
Benzinga
BioXcel Stock Surges 19% In After-Hours Trading: What You Need To Know
↗
August 27, 2025
BioXcel Therapeutics shares surged over 19% after hours ahead of key Phase 3 trial results for its at-home agitation treatment, sparking strong investor interest.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
August 26, 2025
Via
Benzinga
Get insights into the top gainers and losers of Tuesday's after-hours session.
↗
August 26, 2025
As the regular session of the US market concludes on Tuesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
